ArticleClinical immunology (Orlando, Fla.)2022

The FCGR2A rs1801274 polymorphism was associated with the risk of death among COVID-19 patients.

Rocío López-Martínez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.